These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17694480)

  • 21. Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
    Pande AC; Crockatt JG; Feltner DE; Janney CA; Smith WT; Weisler R; Londborg PD; Bielski RJ; Zimbroff DL; Davidson JR; Liu-Dumaw M
    Am J Psychiatry; 2003 Mar; 160(3):533-40. PubMed ID: 12611835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain.
    De Salas-Cansado M; Álvarez E; Olivares JM; Carrasco JL; Ferro MB; Rejas J
    Soc Psychiatry Psychiatr Epidemiol; 2013 Jun; 48(6):985-96. PubMed ID: 23086587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model.
    Nutt D; Mandel F; Baldinetti F
    J Psychopharmacol; 2009 Nov; 23(8):867-73. PubMed ID: 18635690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder.
    Kasper S; Iglesias-García C; Schweizer E; Wilson J; DuBrava S; Prieto R; Pitman VW; Knapp L
    Int J Neuropsychopharmacol; 2014 May; 17(5):685-95. PubMed ID: 24351233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies.
    Stein DJ; Baldwin DS; Baldinetti F; Mandel F
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):422-30. PubMed ID: 18359203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis of the efficacy of pregabalin in the treatment of generalized anxiety disorder.
    Boschen MJ
    Can J Psychiatry; 2011 Sep; 56(9):558-66. PubMed ID: 21959031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregabalin: new indication. Generalised anxiety: better to use benzodiazepine.
    Prescrire Int; 2007 Jun; 16(89):104. PubMed ID: 17582925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Feltner D; Hill C; Lenderking W; Williams V; Morlock R
    J Psychiatr Res; 2009 Oct; 43(15):1224-30. PubMed ID: 19423131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregabalin for the treatment of generalised anxiety disorder.
    Montgomery SA
    Expert Opin Pharmacother; 2006 Oct; 7(15):2139-54. PubMed ID: 17020438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.
    Rickels K; Shiovitz TM; Ramey TS; Weaver JJ; Knapp LE; Miceli JJ
    Int Clin Psychopharmacol; 2012 May; 27(3):142-50. PubMed ID: 22302014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing.
    Pohl RB; Feltner DE; Fieve RR; Pande AC
    J Clin Psychopharmacol; 2005 Apr; 25(2):151-8. PubMed ID: 15738746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies.
    Pollack MH; Meoni P; Otto MW; Simon N; Hackett D
    J Clin Psychopharmacol; 2003 Jun; 23(3):250-9. PubMed ID: 12826987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.
    Coric V; Feldman HH; Oren DA; Shekhar A; Pultz J; Dockens RC; Wu X; Gentile KA; Huang SP; Emison E; Delmonte T; D'Souza BB; Zimbroff DL; Grebb JA; Goddard AW; Stock EG
    Depress Anxiety; 2010 May; 27(5):417-25. PubMed ID: 20455246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregabalin for generalised anxiety disorder.
    Drug Ther Bull; 2010 Feb; 48(2):19-22. PubMed ID: 20147432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early response and 8-week treatment outcome in GAD.
    Rynn M; Khalid-Khan S; Garcia-Espana JF; Etemad B; Rickels K
    Depress Anxiety; 2006; 23(8):461-5. PubMed ID: 16845651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder.
    Montgomery S; Chatamra K; Pauer L; Whalen E; Baldinetti F
    Br J Psychiatry; 2008 Nov; 193(5):389-94. PubMed ID: 18978320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.